DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories
02 1NanoAlvand
03 8Adienne
04 2Amgen Inc
05 2Beloteca
06 1Fresenius Kabi USA
07 2GLAND PHARMA LIMITED
08 1GetWell Pharmaceutical
09 3Hikma Pharmaceuticals
10 1Jiangsu Hengrui Medicine
11 2MIKLICH LABORATORIOS S.L.
12 2MSN Laboratories
13 2Meitheal Pharmaceuticals
14 1Penn Life Sciences
15 2STERIMAX INC
16 1Shorla Oncology
17 2Teva Pharmaceutical Industries
18 2TherDose Pharma
19 2Tobio Novelfarma
20 1West-ward Pharmaceutical Corp
01 10INJECTABLE;INJECTION
02 3Injection
03 2Lyophilized Powder for Injectable Solution
04 2POWDER FOR CONCENTRATE FOR
05 6POWDER FOR SOLUTION
06 10POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
07 2Powder to concentrate to the infusion fluid, resolution
08 1SOLUTION;INTRAVENOUS
09 1Thiotepa 100Mg 10Ml 1 Units Parenteral Use
10 1Thiotepa 15Mg 1.5 Ml 1 Units Parenteral Use
11 1Vial
01 5DISCN
02 6Prescription
03 16RX
04 12Blank
01 6TEPADINA
02 2TEPASYL
03 1TEPAWEL
04 1TEPYLUTE
05 1THIOPLEX
06 17THIOTEPA
07 2THIOTEPA FOR INJECTION USP
08 2THIOTEPA FOR INJECTION, BP
09 2THIOTHER
10 2Tepa Dina
11 2Tepadina
12 1Tinopa
01 6Canada
02 3India
03 1Iran
04 2Italy
05 2Norway
06 2Sweden
07 2Turkey
08 21USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : THIOTEPA
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 15MG/VIAL
Packaging :
Approval Date : 2018-05-04
Application Number : 210337
Regulatory Info : RX
Registration Country : USA
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Tinopa
Dosage Form : Vial
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info : RX
Registration Country : USA
Brand Name : TEPADINA
Dosage Form : POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
Dosage Strength : 15MG/VIAL
Packaging :
Approval Date : 2017-01-26
Application Number : 208264
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TEPADINA
Dosage Form : POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2017-01-26
Application Number : 208264
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Sweden
Brand Name : TEPADINA
Dosage Form : POWDER FOR CONCENTRATE FOR
Dosage Strength : 100 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : TEPADINA
Dosage Form : POWDER FOR CONCENTRATE FOR
Dosage Strength : 15MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Norway
Brand Name : Tepa Dina
Dosage Form : Powder to concentrate to the infusion fluid, resolution
Dosage Strength : 100 mg
Packaging : Hood glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Tepa Dina
Dosage Form : Powder to concentrate to the infusion fluid, resolution
Dosage Strength : 15 mg
Packaging : Hood glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info : DISCN
Registration Country : USA
Brand Name : THIOTEPA
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 15MG/VIAL
Packaging :
Approval Date : 1982-01-01
Application Number : 11683
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : THIOPLEX
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 15MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1994-12-22
Application Number : 20058
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : THIOTEPA
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 15MG/VIAL
Packaging :
Approval Date : 2021-12-08
Application Number : 211831
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : THIOTEPA
Dosage Form : POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
Dosage Strength : 15MG/VIAL
Packaging :
Approval Date : 2024-08-20
Application Number : 217559
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : THIOTEPA
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 15MG/VIAL
Packaging :
Approval Date : 2001-09-20
Application Number : 75698
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : India
Brand Name : TEPAWEL
Dosage Form : Injection
Dosage Strength : 15MG
Packaging : 1 Vial
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : THIOTEPA
Dosage Form : POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
Dosage Strength : 15MG/VIAL
Packaging :
Approval Date : 2021-03-08
Application Number : 214222
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : THIOTEPA
Dosage Form : POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2022-01-03
Application Number : 214222
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : THIOTEPA
Dosage Form : POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2023-09-05
Application Number : 211755
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : THIOTEPA
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 15MG/VIAL
Packaging :
Approval Date : 2018-05-04
Application Number : 209150
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : THIOTEPA
Dosage Form : POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
Dosage Strength : 15MG/VIAL
Packaging :
Approval Date : 2023-12-26
Application Number : 216037
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : THIOTEPA
Dosage Form : POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2023-12-26
Application Number : 216037
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : THIOTEPA
Dosage Form : POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
Dosage Strength : 15MG/VIAL
Packaging :
Approval Date : 2020-03-04
Application Number : 213049
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : THIOTEPA
Dosage Form : POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2020-03-04
Application Number : 213049
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : THIOTEPA
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 15MG/VIAL
Packaging :
Approval Date : 2020-01-10
Application Number : 208242
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TEPYLUTE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 15MG/1.5ML (10MG/ML)
Packaging :
Approval Date : 2024-06-25
Application Number : 216984
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : THIOTEPA
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 15MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2001-04-20
Application Number : 75730
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : THIOTEPA
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 30MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2001-04-20
Application Number : 75730
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : Turkey
Brand Name : TEPASYL
Dosage Form : Lyophilized Powder for Injectable Solution
Dosage Strength : 100MG
Packaging : 1 Vial/ Box
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Regulatory Info : RX
Registration Country : USA
Brand Name : THIOTEPA
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 15MG/VIAL
Packaging :
Approval Date : 2001-04-02
Application Number : 75547
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Brand Name : Tepadina
Dosage Form : Thiotepa 100Mg 10Ml 1 Units Parenteral Use
Dosage Strength : 1 ampoule EV 100 mg 10 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Tepadina
Dosage Form : Thiotepa 15Mg 1.5 Ml 1 Units Parenteral Use
Dosage Strength : 1 ampoule EV 15 mg 10 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?
